APOBEC3B reporter myeloma cell lines identify DNA damage response pathways leading to APOBEC3B expression
Open Access
- 8 January 2020
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (1) , e0223463
Abstract
Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like (APOBEC) DNA cytosine deaminase 3B (A3B) is a DNA editing enzyme which induces genomic DNA mutations in multiple myeloma and in various other cancers. APOBEC family proteins are highly homologous so it is especially difficult to investigate the biology of specifically A3B in cancer cells. To easily and comprehensively investigate A3B function in myeloma cells, we used CRISPR/Cas9 to generate A3B reporter cells that contain 3×FLAG tag and IRES-EGFP sequences integrated at the end of the A3B gene. These reporter cells stably express 3xFLAG tagged A3B and the reporter EGFP and this expression is enhanced by known stimuli, such as PMA. Conversely, shRNA knockdown of A3B decreased EGFP fluorescence and 3xFLAG tagged A3B protein levels. We screened a series of anticancer treatments using these cell lines and identified that most conventional therapies, such as antimetabolites or radiation, exacerbated endogenous A3B expression, but recent molecular targeted therapeutics, including bortezomib, lenalidomide and elotuzumab, did not. Furthermore, chemical inhibition of ATM, ATR and DNA-PK suppressed EGFP expression upon treatment with antimetabolites. These results suggest that DNA damage triggers A3B expression through ATM, ATR and DNA-PK signaling.Keywords
All Related Versions
This publication has 69 references indexed in Scilit:
- Signatures of mutational processes in human cancerNature, 2013
- DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegiseLife, 2013
- APOBEC3B is an enzymatic source of mutation in breast cancerNature, 2013
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- APOBEC3B can impair genomic stability by inducing base substitutions in genomic DNA in human cellsScientific Reports, 2012
- A telomere-dependent DNA damage checkpoint induced by prolonged mitotic arrestNature Structural & Molecular Biology, 2012
- CGK733 does not inhibit ATM or ATR kinase activity in H460 human lung cancer cellsDNA Repair, 2011
- Proteasome inhibition suppresses DNA-dependent protein kinase activation caused by camptothecinDNA Repair, 2010
- Topoisomerase I suppresses genomic instability by preventing interference between replication and transcriptionNature Cell Biology, 2009
- Targeting DNA topoisomerase II in cancer chemotherapyNature Reviews Cancer, 2009